Chronic hand eczema and hepatogenic pruritus with good response to apremilast.

Author: Cuenca-BarralesCarlos, Navarro-TriviñoFrancisco J, Ruiz-VillaverdeRicardo, Vega-CastilloJorge J

Paper Details 
Original Abstract of the Article :
Hand eczema (HE) presents a high prevalence and severe impact on the quality of life of the patients. HE is a worldwide problem recognized for his high socio-occupational involvement. Treatment is mainly based on adequate recommendations for hand care together with topical anti-inflammatory treatmen...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/dth.12879

データ提供:米国国立医学図書館(NLM)

Apremilast for Hand Eczema: A New Oasis in the Desert

In the vast and often itchy desert of dermatological research, we're constantly seeking treatments for chronic skin conditions like hand eczema. This study, like a camel seeking a refreshing spring, investigates the potential of apremilast, an oral medication, for the treatment of hand eczema. The authors present a case report, a glimpse into a specific patient's journey, showcasing the remarkable response of hand eczema to apremilast treatment. The study suggests that apremilast may offer a new therapeutic option for patients with hand eczema, potentially providing relief from the persistent inflammation and itching.

Apremilast: A Potential Solution for Hand Eczema

This study, like a beacon in the desert, highlights the potential of apremilast for treating hand eczema. The case report demonstrates a significant improvement in the patient's condition, suggesting that apremilast may offer a valuable alternative to traditional treatments. The findings serve as a catalyst for further research and clinical trials to explore the efficacy and safety of apremilast for hand eczema.

Navigating the Desert of Hand Eczema

This study, like a compass pointing towards a new treatment approach, guides us towards a deeper understanding of hand eczema and its management. The research suggests that apremilast may offer a potential solution for patients suffering from this chronic condition, potentially providing relief from the persistent itching and inflammation. This study reinforces the importance of continued research and innovation in the field of dermatology.

Dr.Camel's Conclusion

This research, like a camel discovering a hidden oasis, explores the potential of apremilast for treating hand eczema. The case report offers a promising glimpse into the therapeutic potential of this medication, providing hope for patients seeking relief from this chronic condition. As researchers, we must continue our journey, seeking to uncover new treatments and improve the lives of those living with chronic skin conditions.

Date :
  1. Date Completed 2020-01-14
  2. Date Revised 2020-01-14
Further Info :

Pubmed ID

30912252

DOI: Digital Object Identifier

10.1111/dth.12879

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.